There's Plenty of Opportunity for Biotech Post-Coronavirus

While the Coronavirus pandemic continues dominating healthcare sector headlines, investors shouldn’t fret that biotechnology ETFs will be left vulnerable when the virus is finally vanquished. That’s good news for the First Trust NYSE Arca Biotechnology Index Fund ( FBT C ), among other biotech ETFs.